Mike McEwan
Overview
Explore the profile of Mike McEwan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Camacho O, Hedge A, Lowe F, Newland N, Gale N, McEwan M, et al.
Contemp Clin Trials Commun
. 2020 Feb;
17:100535.
PMID: 32072070
Tobacco harm reduction strategies aim to substitute smoking with potentially reduced risk products (PRRPs) such as e-cigarettes and tobacco-heating products (THPs). The health benefits of switching from smoking to PRRPs...
2.
Newland N, Lowe F, Camacho O, McEwan M, Gale N, Ebajemito J, et al.
Intern Emerg Med
. 2019 May;
14(6):885-898.
PMID: 31049783
Tobacco heating products (THPs) are a potentially safer alternative to combustible cigarette smoking. Through continued use, THPs may reduce smoking-related disease risk, whilst maintaining the sensorial experience and nicotine delivery...
3.
Fearon I, Eldridge A, Gale N, McEwan M, Stiles M, Round E
Regul Toxicol Pharmacol
. 2018 Sep;
100:25-34.
PMID: 30201538
E-cigarettes are battery-powered electronic devices from which users can inhale nicotine following its aerosolisation from a liquid solution. Some regulators and public health bodies consider e-cigarettes as potentially playing a...
4.
Gale N, McEwan M, Eldridge A, Fearon I, Sherwood N, Bowen E, et al.
Nicotine Tob Res
. 2018 Jun;
21(9):1220-1227.
PMID: 29912406
Background: Smoking is a leading cause of numerous human disorders including pulmonary disease, cardiovascular disease, and cancer. Disease development is primarily caused by exposure to cigarette smoke constituents, many of...
5.
Gale N, McEwan M, Eldridge A, Sherwood N, Bowen E, McDermott S, et al.
BMC Public Health
. 2017 Aug;
17(1):673.
PMID: 28830420
Background: Smoking is a leading cause of numerous human disorders including lung cancer, chronic obstructive pulmonary disease, and atherosclerotic cardiovascular disease. The development of modified risk tobacco products (MRTPs) has...
6.
Fearon I, Eldridge A, Gale N, Shepperd C, McEwan M, Camacho O, et al.
Am J Health Behav
. 2016 Dec;
41(1):16-32.
PMID: 27935787
Objectives: E-cigarettes could potentially play a major role in tobacco harm reduction by delivering nicotine in a vapor containing significantly fewer toxicants than cigarette smoke and may aid smoking behavior...
7.
Izzo R, Di Renzo G, De Luca N, Trimarco V, Buono F, Crispo S, et al.
High Blood Press Cardiovasc Prev
. 2013 Jan;
15(4):269-73.
PMID: 23355129
Background And Objectives: Left ventricular hypertrophy, carotid atherosclerosis and renal dysfunction are indicators of target organ damage in hypertension, and independent risk factors for both fatal and non-fatal cardio- and...
8.
Minet E, Errington G, Scherer G, Newland K, Sharifi M, Bailey B, et al.
BMC Res Notes
. 2011 Oct;
4:391.
PMID: 21985092
Background: Biomarkers have been used extensively in clinical studies to assess toxicant exposure in smokers and non-smokers and have recently been used in the evaluation of novel tobacco products. The...
9.
Ramsauer B, Sterz K, Hagedorn H, Engl J, Scherer G, McEwan M, et al.
Anal Bioanal Chem
. 2010 Nov;
399(2):877-89.
PMID: 21046075
Polycyclic aromatic hydrocarbons (PAH) are products of the incomplete combustion of organic materials and, therefore, occur ubiquitously in the environment and also in tobacco smoke. Since some PAH have been...
10.
Calapai G, Caputi A, Mannucci C, Gregg E, Pieratti A, Aurora Russo G, et al.
Inhal Toxicol
. 2009 Oct;
21(13):1138-43.
PMID: 19852556
Two groups of 20 healthy volunteers with cigarettes of different tar yield were compared with a group of 20 never smokers over 24 h for several biomarkers. All groups were...